Found: 104
Select item for more details and to access through your institution.
VALIDATION OF SURROGATE ENDPOINTS IN ADVANCED SOLID TUMORS: SYSTEMATIC REVIEW OF STATISTICAL METHODS, RESULTS, AND IMPLICATIONS FOR POLICY MAKERS.
- Published in:
- International Journal of Technology Assessment in Health Care, 2014, v. 30, n. 3, p. 312, doi. 10.1017/S0266462314000300
- By:
- Publication type:
- Article
Impact of cyclins E, neutrophil elastase and proteinase 3 expression levels on clinical outcome in primary breast cancer patients.
- Published in:
- International Journal of Cancer, 2006, v. 119, n. 11, p. 2539, doi. 10.1002/ijc.22149
- By:
- Publication type:
- Article
Common pitfalls in statistical analysis: The perils of multiple testing.
- Published in:
- Perspectives in Clinical Research, 2016, v. 7, n. 2, p. 106, doi. 10.4103/2229-3485.179436
- By:
- Publication type:
- Article
Common pitfalls in statistical analysis: Clinical versus statistical significance.
- Published in:
- Perspectives in Clinical Research, 2015, v. 6, n. 3, p. 169, doi. 10.4103/2229-3485.159943
- By:
- Publication type:
- Article
Common pitfalls in statistical analysis: "P" values, statistical significance and confidence intervals.
- Published in:
- Perspectives in Clinical Research, 2015, v. 6, n. 2, p. 116, doi. 10.4103/2229-3485.154016
- By:
- Publication type:
- Article
Common pitfalls in statistical analysis: "No evidence of effect" versus "evidence of no effect".
- Published in:
- Perspectives in Clinical Research, 2015, v. 6, n. 1, p. 62, doi. 10.4103/2229-3485.148821
- By:
- Publication type:
- Article
On the use of extreme value tail modeling for generalized pairwise comparisons with censored outcomes.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 2, p. 284, doi. 10.1002/pst.2271
- By:
- Publication type:
- Article
Using an interim analysis based exclusively on an early outcome in a randomized clinical trial with a long‐term clinical endpoint.
- Published in:
- Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 209, doi. 10.1002/pst.2165
- By:
- Publication type:
- Article
Surrogate threshold effect: an alternative measure for meta-analytic surrogate endpoint validation.
- Published in:
- Pharmaceutical Statistics, 2006, v. 5, n. 3, p. 173, doi. 10.1002/pst.207
- By:
- Publication type:
- Article
Comparison of the Levogyre and Dextro-Levogyre Forms of Leucovorin in a Phase III Trial of Bimonthly LV5FU2 Versus Monthly 5-Fluorouracil and High-Dose Leucovorin for Patients With Stage II and III Colon Cancer (GERCOR C96.1).
- Published in:
- Clinical Colorectal Cancer, 2010, v. 9, n. 2, p. E5, doi. 10.3816/CCC.2010.n.027
- By:
- Publication type:
- Article
Authors' Reply to Schoenfeld: 'Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors'.
- Published in:
- Drugs, 2017, v. 77, n. 10, p. 1139, doi. 10.1007/s40265-017-0761-x
- By:
- Publication type:
- Article
Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors.
- Published in:
- Drugs, 2017, v. 77, n. 7, p. 713, doi. 10.1007/s40265-017-0728-y
- By:
- Publication type:
- Article
Validation of surrogate end points in multiple randomized clinical trials with failure time end points.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 2001, v. 50, n. 4, p. 405, doi. 10.1111/1467-9876.00244
- By:
- Publication type:
- Article
Design of a clinical trial using generalized pairwise comparisons to test a less intensive treatment regimen.
- Published in:
- Clinical Trials, 2024, v. 21, n. 2, p. 180, doi. 10.1177/17407745231206465
- By:
- Publication type:
- Article
Commentary on Bamat et al.
- Published in:
- Clinical Trials, 2020, v. 17, n. 5, p. 560, doi. 10.1177/1740774520941442
- By:
- Publication type:
- Article
Open science: The open clinical trials data journey.
- Published in:
- Clinical Trials, 2019, v. 16, n. 5, p. 539, doi. 10.1177/1740774519865512
- By:
- Publication type:
- Article
Detection of atypical data in multicenter clinical trials using unsupervised statistical monitoring.
- Published in:
- Clinical Trials, 2019, v. 16, n. 5, p. 512, doi. 10.1177/1740774519862564
- By:
- Publication type:
- Article
The impact of data errors on the outcome of randomized clinical trials.
- Published in:
- Clinical Trials, 2017, v. 14, n. 5, p. 499, doi. 10.1177/1740774517716158
- By:
- Publication type:
- Article
Commentary on Hey and Kimmelman.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 119, doi. 10.1177/1740774515568916
- By:
- Publication type:
- Article
A statistical approach to central monitoring of data quality in clinical trials.
- Published in:
- Clinical Trials, 2012, v. 9, n. 6, p. 705, doi. 10.1177/1740774512447898
- By:
- Publication type:
- Article
Minimization in randomized clinical trials.
- Published in:
- Statistics in Medicine, 2023, v. 42, n. 28, p. 5285, doi. 10.1002/sim.9916
- By:
- Publication type:
- Article
Individualized Net Benefit estimation and meta‐analysis using generalized pairwise comparisons in N‐of‐1 trials.
- Published in:
- Statistics in Medicine, 2023, v. 42, n. 6, p. 878, doi. 10.1002/sim.9648
- By:
- Publication type:
- Article
Net benefit in the presence of correlated prioritized outcomes using generalized pairwise comparisons: A simulation study.
- Published in:
- Statistics in Medicine, 2021, v. 40, n. 3, p. 553, doi. 10.1002/sim.8788
- By:
- Publication type:
- Article
Comparison of prognostic gene expression signatures for breast cancer.
- Published in:
- BMC Genomics, 2008, v. 9, p. 1, doi. 10.1186/1471-2164-9-394
- By:
- Publication type:
- Article
Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 128, n. 1, p. 163, doi. 10.1007/s11060-016-2094-0
- By:
- Publication type:
- Article
Statistical evaluation of surrogate endpoints with examples from cancer clinical trials.
- Published in:
- Biometrical Journal, 2016, v. 58, n. 1, p. 104, doi. 10.1002/bimj.201400049
- By:
- Publication type:
- Article
Validation of Surrogate Endpoints in Multiple Randomized Clinical Trials with Discrete Outcomes.
- Published in:
- Biometrical Journal, 2002, v. 44, n. 8, p. 921, doi. 10.1002/bimj.200290004
- By:
- Publication type:
- Article
Adjuvant Chemotherapy With Sequential or Concurrent Anthracycline and Docetaxel: Breast International Group 02-98 Randomized Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 2, p. 121, doi. 10.1 093/i nci/djm287
- By:
- Publication type:
- Article
Endpoints in Adjuvant Treatment Trials: A Systematic Review of the Literature in Colon Cancer and Proposed Definitions for Future Trials.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 13, p. 998, doi. 10.1093/jnci/djm024
- By:
- Publication type:
- Article
Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 17, p. 1183, doi. 10.1093/jnci/djj329
- By:
- Publication type:
- Article
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 4, p. 262, doi. 10.1093/jnci/djj052
- By:
- Publication type:
- Article
Taxanes in the Adjuvant Treatment of Breast Cancer: Why Not Yet?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2001, v. 93, n. 30, p. 88
- By:
- Publication type:
- Article
Relationship Between Carfilzomib Dose and Efficacy Outcomes in Patients With Relapsed and/or Refractory Multiple Myeloma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Cell kinetic indicators of premalignant stages of colorectal cancer.
- Published in:
- 1985
- By:
- Publication type:
- journal article
Interim analysis of a phase III study on preoperative radiation therapy in resectable rectal carcinoma. Trial of the Gastrointestinal Tract Cancer Cooperative Group of the European Organization for Research on Treatment of Cancer (EORTC).
- Published in:
- 1985
- By:
- Publication type:
- journal article
The case against censoring of progression-free survival in cancer clinical trials - A pandemic shutdown as an illustration.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 152, n. 2, p. 399, doi. 10.1007/s10549-015-3466-4
- By:
- Publication type:
- Article
Statistical monitoring of data quality and consistency in the Stomach Cancer Adjuvant Multi-institutional Trial Group Trial.
- Published in:
- Gastric Cancer, 2016, v. 19, n. 1, p. 24, doi. 10.1007/s10120-015-0533-9
- By:
- Publication type:
- Article
Assessment of Statistical Heterogeneity in the PLATO Trial.
- Published in:
- Cardiology, 2011, v. 118, n. 2, p. 138, doi. 10.1159/000327592
- By:
- Publication type:
- Article
Time to deterioration of patient-reported outcomes as a surrogate of overall survival: a meta-analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 12, p. 1475, doi. 10.1093/jnci/djad152
- By:
- Publication type:
- Article
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II-III Melanoma Adjuvant Therapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2018, v. 110, n. 1, p. 1, doi. 10.1093/jnci/djx133
- By:
- Publication type:
- Article
The Development of Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-Analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 21, p. 1600, doi. 10.1093/jnci/djt270
- By:
- Publication type:
- Article
Adjuvant reactivity predicts survival in patients with 'high-risk' primary malignant melanoma treated with systemic BCG.
- Published in:
- International Journal of Cancer, 1981, v. 28, n. 5, p. 543, doi. 10.1002/ijc.2910280503
- By:
- Publication type:
- Article
Central statistical monitoring of investigator-led clinical trials in oncology.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 7, p. 1207, doi. 10.1007/s10147-020-01726-6
- By:
- Publication type:
- Article
Meta-analysis of randomized clinical trials in the era of individual patient data sharing.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 3, p. 403, doi. 10.1007/s10147-018-1237-z
- By:
- Publication type:
- Article
Fraud in clinical trials: complex problem, simple solutions?
- Published in:
- International Journal of Clinical Oncology, 2016, v. 21, n. 1, p. 13, doi. 10.1007/s10147-015-0922-4
- By:
- Publication type:
- Article